| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Dec 1, 2022 | Carrick Therapeutics | Series C | — | Biotechnology | — |
| Nov 29, 2022 | Cajal Neuroscience | Series A | — | Biotechnology | — |
| May 3, 2022 | Tubulis | Series B | — | Biotechnology | — |
| Feb 16, 2022 | Centauri Therapeutics | Series A | — | Biotechnology | — |
| Feb 15, 2022 | IMIDomics | Corporate Round | — | Biotechnology | Yes |
| Aug 18, 2021 | Immunitas Therapeutics | Series B | — | Biotechnology | — |
| Jul 29, 2021 | Topas Therapeutics | Series B | — | Advanced Materials | — |
| Apr 21, 2021 | OxVax | Seed | — | Biotechnology | Yes |
| Mar 4, 2021 | Exscientia | Series C | — | Artificial Intelligence | — |
| Mar 2, 2021 | ARGOBIO | Funding Round | — | Biotechnology | — |
| Jan 8, 2021 | Blacksmith Medicines | Seed | — | Biotechnology | — |
| Jun 24, 2020 | Autobahn Labs | Seed | — | Biotechnology | Yes |
| May 26, 2020 | Exscientia | Series C | — | Artificial Intelligence | — |
| Apr 16, 2020 | leon nanodrugs | Series B | — | Biotechnology | — |
| Nov 22, 2019 | Immunitas Therapeutics | Series A | — | Biotechnology | — |
| Jul 9, 2019 | Breakpoint Therapeutics | Series Unknown | — | Biotechnology | — |
| Apr 1, 2019 | Celmatix | Series Unknown | — | Biotechnology | — |
| Jan 7, 2019 | Exscientia | Series B | — | Artificial Intelligence | — |
| Sep 28, 2017 | Exscientia | Series A | — | Artificial Intelligence | Yes |
| Apr 25, 2017 | Forge Therapeutics | Series A | — | Biotechnology | — |
| Jan 9, 2017 | Eternygen | Series A | — | Biotechnology | — |
| Oct 3, 2016 | Carrick Therapeutics | Series A | — | Biotechnology | — |
| Dec 2, 2014 | Sanofi | Post-IPO Equity | — | Health Care | Yes |